MRK Today - Aug 13: Merck Gets Upgraded
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
MRK Today - Aug 13: Merck Gets Upgraded
-
Letto da:
-
Di:
A proposito di questo titolo
Now, let’s break it down. The stock was feeling the love today, and it’s mostly thanks to an upgrade from Daiwa. They gave Merck a little boost, saying it’s looking pretty good. That got people excited, and some jumped on the bandwagon. Plus, it didn’t hurt that Merck's been holding its own against competitors lately. While others were struggling, Merck was out here flexing its muscles.
Then, there’s the chatter about Keytruda, Merck's big cancer drug. There’s some buzz around whether it can keep the momentum going in the second half of 2026. Folks are curious if it’ll keep driving growth or if they’ll need to find something else to keep the engine running.
Oh, and just a heads up! One of their big execs, Richard DeLuca, sold off a chunk of shares recently. Not sure what that’s about, but it’s something to keep in mind. It’s always interesting when insiders start moving their shares around.
All in all, Merck had a nice little pop today, riding high on that upgrade and some solid performance. Just remember, I’m here to keep you informed and entertained, but I’m not giving any financial advice. So, keep it chill, and catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione